EU Secures Emergency Hantavirus Treatments
4 Articles
4 Articles
The first doses of an experimental antiviral against hantavirus are sent urgently to France, Spain and the Netherlands after an outbreak on board a cruise ship. The European Commission announces that treatment could be used in the absence of a specific therapy for rodent-borne virus.
The Netherlands is receiving the first doses of "an experimental antiviral drug" for the treatment of hantavirus. The European Commission announced this on Thursday. There are no approved medicines or vaccines yet for treating or preventing the virus, but the European Medicines Agency considers the drug Favipiravir suitable for use in clinical trials.
EU secures emergency hantavirus treatments
The first doses of an experimental antiviral for hantavirus treatment are being dispatched to France, Spain and the Netherlands, the European Commission said on Thursday. In the absence of a specific treatment for hantavirus, the European Medicines Agency identified favipiravir as the most plausible candidate for use under clinical trial or compassionate use protocols, the Commission said in a statement reported by Reuters. The post EU secures …
Brussels distributes 1,400 experimental tablets between France, Spain and the Netherlands while accelerating emergency purchases in the face of fear of new contagions.
Coverage Details
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
Factuality
To view factuality data please Upgrade to Premium
